Top Veterinary Diagnostics Companies

Veterinary Diagnostics Market size was valued at USD 9.01 Billion in 2024 and is poised to grow from USD 10.02 Billion in 2025 to USD 23.42 Billion by 2033, growing at a CAGR of 11.2% during the forecast period (2026–2033).

The global veterinary diagnostics market is highly competitive, with numerous players focusing on innovation and advanced technology. Reputable organizations include IDEXX Laboratories, Zoetis, and Neogen Corporation well-known for providing comprehensive diagnostics solutions. Some of the other key players in the market include Bayer Animal Health, Roche Diagnostics, and Thermo Fisher Scientific. Such firms channel a substantial amount of their finances in the improvement of their already existing items as a response to the growing demand for fast and reliable diagnosis systems for pet and farm animals. 'IDEXX Laboratories, Inc. (United States)', 'Zoetis Inc. (United States) ', 'Thermo Fisher Scientific Inc. (United States) ', 'bioMerieux SA (France) ', 'Heska Corporation (United States) ', 'NEOGEN Corporation (United States) ', 'Bio-Rad Laboratories, Inc. (United States) ', 'Virbac (France) ', 'FUJIFILM Holdings Corporation (Japan) ', 'Shenzhen Mindray Animal Medical Technology Co., Ltd. (China) ', 'INDICAL BIOSCIENCE GmbH (Germany) ', 'BioNote, Inc. (South Korea) ', 'Biogal Galed Labs (Israel) ', 'Agrolabo S.p.A. (Italy) ', 'Innovative Diagnostics (France) ', 'Randox Laboratories Ltd. (United Kingdom) ', 'BioChek BV (Netherlands) ', 'Fassisi GmbH (Germany) ', 'Alvedia (France) ', 'SKYER, Inc. (South Korea)'

The expansion of the global veterinary diagnostics market is also attributed to soaring pet ownership levels as more pet parents tend to pursue the best health care services for their pets. While the previously unrecognized and enormous proportion of pet owners was always present in most urban zones has contributed to all this. This increases the upward trend for preventive-care, early diagnosis, and routine-diagnosis, increasing the scope of veterinary diagnostics services remarkably. 

Increasing Adoption of Point-of-Care Testing: The point-of-care testing is gaining traction as a growing trend in the global veterinary diagnostics industry, which makes a rapid diagnosis possible and thus a treatment can be given in a clinical setting. This trend improves the effectiveness of the veterinary working environment as it cuts down the time when pet owners must wait for veterinary services and helps in controlling the spread of the disease especially to pets which are more of companions. 

North America dominates the global veterinary diagnostics market, driven by high pet ownership, advanced veterinary infrastructure, and significant investments in veterinary healthcare. The region's emphasis on pet wellbeing and on the ways to which diseases can be detected and treated early in pets coupled with preventive care has led to the increase in demand for sophisticated technologies for diagnosis especially in molecular and biochemical testing. Moreover, the strong support of governmental activities and increase in the awareness of zoonoses led to an increase in testing within animals. The presence of major players in the global veterinary diagnostics market and development of sophisticated diagnostic technologies still help to strengthen North America's position in the industry. Such a well-developed ecosystem also makes this region a geographical epicenter of veterinary diagnostics innovations.